StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Monday. The firm issued a hold rating on the software maker’s stock.
Separately, TD Cowen dropped their price objective on shares of Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a research note on Tuesday, May 28th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Veradigm presently has an average rating of Hold and a consensus price target of $12.00.
Check Out Our Latest Stock Report on MDRX
Veradigm Stock Down 1.8 %
Institutional Trading of Veradigm
Several hedge funds have recently bought and sold shares of MDRX. Innealta Capital LLC bought a new position in Veradigm in the 2nd quarter worth about $38,000. TFO Wealth Partners LLC grew its holdings in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after buying an additional 5,264 shares in the last quarter. Gladius Capital Management LP increased its position in Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after acquiring an additional 3,587 shares during the period. Meadow Creek Wealth Advisors LLC bought a new stake in Veradigm during the 1st quarter valued at $83,000. Finally, Headlands Technologies LLC boosted its position in Veradigm by 14,907.7% during the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after acquiring an additional 9,690 shares during the period.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What Are Dividend Contenders? Investing in Dividend Contenders
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- The Most Important Warren Buffett Stock for Investors: His Own
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Golden Cross Stocks: Pattern, Examples and Charts
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.